1. Home
  2. TEVA vs KMB Comparison

TEVA vs KMB Comparison

Compare TEVA & KMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

SELL

Current Price

$40.88

Market Cap

40.5B

Sector

Health Care

ML Signal

SELL

Logo Kimberly-Clark Corporation

KMB

Kimberly-Clark Corporation

SELL

Current Price

$99.38

Market Cap

32.5B

ML Signal

SELL

Company Overview

Basic Information
Metric
TEVA
KMB
Founded
1901
1910
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
40.5B
32.5B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
TEVA
KMB
Price
$40.88
$99.38
Analyst Decision
Strong Buy
Buy
Analyst Count
13
16
Target Price
$47.17
★ $114.80
AVG Volume (30 Days)
★ 5.3M
3.9M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
★ 5.21%
EPS Growth
★ 183.45
N/A
EPS
N/A
★ 3.03
Revenue
N/A
★ $16,447,000,000.00
Revenue This Year
N/A
$0.85
Revenue Next Year
$3.39
$2.68
P/E Ratio
★ N/A
$32.44
Revenue Growth
★ N/A
N/A
52 Week Low
$18.83
$92.42
52 Week High
$42.02
$123.09

Technical Indicators

Market Signals
Indicator
TEVA
KMB
Relative Strength Index (RSI) 62.59 50.67
Support Level $30.41 $97.28
Resistance Level N/A $100.05
Average True Range (ATR) 1.06 1.79
MACD 0.07 0.67
Stochastic Oscillator 69.76 91.58

Price Performance

Historical Comparison
TEVA
KMB

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About KMB Kimberly-Clark Corporation

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.

Share on Social Networks: